Have a feature idea you'd love to see implemented?
Let us know!
NURO NeuroMetrix Inc
Price (delayed)
$3.96
Market cap
$8.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.55
Enterprise value
$7.31M
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. The Company has
Highlights
NeuroMetrix's debt has decreased by 47% YoY and by 19% QoQ
NURO's EPS is up by 19% YoY and by 17% QoQ
NURO's net income is down by 38% YoY but it is up by 3.3% QoQ
NURO's quick ratio is up by 18% since the previous quarter but it is down by 15% year-on-year
NeuroMetrix's gross profit has decreased by 50% YoY and by 18% from the previous quarter
NURO's revenue is down by 41% year-on-year and by 14% since the previous quarter
Key stats
What are the main financial stats of NURO
Market
Valuations
Earnings
Shares outstanding
2.04M
Market cap
$8.09M
Enterprise value
$7.31M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.5
Price to sales (P/S)
2.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.94
Revenue
$3.77M
Gross profit
$2.17M
Net income
-$7.68M
EBIT
-$7.68M
EBITDA
-$7.47M
Free cash flow
-$6.73M
Per share
Balance sheet
Liquidity
EPS
-$4.55
EPS diluted
-$4.55
Free cash flow per share
-$3.33
Book value per share
$7.89
Revenue per share
$1.86
TBVPS
$8.5
Total assets
$17.19M
Total liabilities
$1.21M
Debt
$142,621
Equity
$15.98M
Working capital
$15.59M
Debt to equity
0.01
Current ratio
13.88
Quick ratio
12.38
Net debt/EBITDA
0.1
Margins
Efficiency
Dividend
EBITDA margin
-198.4%
Gross margin
57.6%
Net margin
-203.7%
Operating margin
-230.4%
Return on assets
-39.3%
Return on equity
-42.6%
Return on invested capital
-45.4%
Return on capital employed
-48%
Return on sales
-203.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NURO stock price
How has the NeuroMetrix stock price performed over time
Intraday
0.51%
1 week
0.25%
1 month
-7.26%
1 year
10%
YTD
10%
QTD
-0.25%
Financial performance
How have NeuroMetrix's revenue and profit performed over time
Revenue
$3.77M
Gross profit
$2.17M
Operating income
-$8.68M
Net income
-$7.68M
Gross margin
57.6%
Net margin
-203.7%
NURO's operating margin has shrunk by 141% YoY and by 13% QoQ
NeuroMetrix's net margin has shrunk by 135% YoY and by 13% QoQ
NeuroMetrix's gross profit has decreased by 50% YoY and by 18% from the previous quarter
NURO's revenue is down by 41% year-on-year and by 14% since the previous quarter
Growth
What is NeuroMetrix's growth rate over time
Valuation
What is NeuroMetrix stock price valuation
P/E
N/A
P/B
0.5
P/S
2.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.94
NURO's EPS is up by 19% YoY and by 17% QoQ
The P/B is 55% below the 5-year quarterly average of 1.1 but 25% above the last 4 quarters average of 0.4
The equity has declined by 20% year-on-year and by 8% since the previous quarter
The stock's price to sales (P/S) is 42% more than its last 4 quarters average of 1.5 and 12% more than its 5-year quarterly average of 1.9
NURO's revenue is down by 41% year-on-year and by 14% since the previous quarter
Efficiency
How efficient is NeuroMetrix business performance
NURO's ROS has shrunk by 135% YoY and by 13% QoQ
NeuroMetrix's ROE has plunged by 66% YoY and by 2.2% from the previous quarter
NURO's ROA has plunged by 63% YoY
The ROIC has plunged by 60% YoY
Dividends
What is NURO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NURO.
Financial health
How did NeuroMetrix financials performed over time
NURO's total liabilities is down by 25% QoQ and by 13% YoY
NeuroMetrix's total assets has decreased by 19% YoY and by 9% QoQ
NeuroMetrix's debt is 99% lower than its equity
NeuroMetrix's debt has decreased by 47% YoY and by 19% QoQ
The equity has declined by 20% year-on-year and by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.